Analyst price target revisions reflect shifting sell-side models, which often lag news and vary by firm methodology.
What the data shows
Between May 21 and May 27, 2026, analysts issued multiple revisions. Upgrades were concentrated in Energy and Healthcare. Barclays raised targets for UNH (373→429) and four energy firms: XOM (163→182), EOG (140→153), COP (136→155), and CVX (192→213). B of A Securities increased targets for AAPL (330→380), LLY (1133→1251), and TXN (320→370). Downgrades included WMT (UBS, RBC, BNP), DE (DA Davidson, B of A), CRM (UBS), and LOW (UBS, Telsey).
| Ticker | Firm | Dir | Prior → Current | Date |
|---|---|---|---|---|
| UNH | Barclays | Up | 373 → 429 | 05-26 |
| XOM | Barclays | Up | 163 → 182 | 05-26 |
| WMT | UBS | Down | 147 → 141 | 05-22 |
| DE | DA Davidson | Down | 775 → 685 | 05-22 |
How to read these figures
A single firm's revision represents one perspective, not a consensus shift. View these as individual analyst adjustments to valuation models. For a full list of recent activity, visit our moves page.
Key takeaways
* Upgrades centered on energy and healthcare, while consumer and industrial names saw downward revisions. * Price target dispersion is common; a single firm's change does not alter the broader market consensus. * Upside figures represent the gap between current market prices and the specific analyst's new target.
Frequently asked questions
What counts as an upgrade?
An upgrade occurs when an analyst increases their 12-month price target, signaling a change in their valuation model.
Is a raise automatically bullish?
Not necessarily; a target raise might simply track a stock's recent price appreciation rather than reflect new growth expectations.